Overexpression of programmed cell death-ligand 1 (PD-L1) in glioma cells prevents activation of T cells and induces T cell apoptosis via binding to programmed death 1 (PD-1), a well-known inhibitory immune checkpoint molecule (32, 33). This evidence concerns the gene CD274 and central nervous system cancer.